Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Praxis Precision Medicines, Inc. | Director | Common Stock | 14.5K | $365K | $25.19 | Oct 5, 2023 | Direct |
iTeos Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 24.2K | Jun 11, 2024 | Direct | ||
Praxis Precision Medicines, Inc. | Director | Stock Option (Right to Buy) | 8.57K | Jun 5, 2024 | Direct | ||
Oncternal Therapeutics, Inc. | Director | Stock Options | 2.2K | Jun 20, 2024 | Direct | ||
Kinnate Biopharma Inc. | Director | Stock Option (right to buy) | 0 | Apr 3, 2024 | Direct |